Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
intramuscular injection
|
| gptkbp:approvalYear |
2022
|
| gptkbp:approvedBy |
gptkb:South_Korea
|
| gptkbp:brand |
gptkb:Skycovione
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:collaboratedWith |
GlaxoSmithKline
|
| gptkbp:containsAdjuvant |
gptkb:AS03
|
| gptkbp:countryOfOrigin |
gptkb:South_Korea
|
| gptkbp:developedBy |
gptkb:SK_Bioscience
|
| gptkbp:dosesRequired |
2
|
| gptkbp:emergencyServices |
gptkb:South_Korea
|
| https://www.w3.org/2000/01/rdf-schema#label |
Skycovione
|
| gptkbp:indication |
prevention of COVID-19
|
| gptkbp:storage |
2-8°C
|
| gptkbp:target |
gptkb:SARS-CoV-2_spike_protein
|
| gptkbp:type |
protein subunit vaccine
|
| gptkbp:bfsParent |
gptkb:GBP510_COVID-19_vaccine
|
| gptkbp:bfsLayer |
7
|